37 results
F-3ASR
LEGN
Legend Biotech Corporation
19 Mar 24
Automatic shelf registration (foreign)
7:57am
plans;
exemption from the requirement that our audit committee have review and oversight responsibilities over all “related party transactions … members would be exercising independent judgment and the level of board oversight on the management of our company may decrease as a result. The foreign
F-3ASR
LEGN
Legend Biotech Corporation
26 May 23
Automatic shelf registration (foreign)
9:01am
Oversight Board is unable to inspect our auditors for two consecutive years as we were identified by the SEC as a Commission-Identified Issuer on May 4
424B5
LEGN
Legend Biotech Corporation
8 May 23
Prospectus supplement for primary offering
8:45am
the Holding Foreign Companies Accountable Act if the Public Company Accounting Oversight Board is unable to inspect our auditors for two consecutive
6-K
EX-99.1
hrc 1vi43ix9m
14 Apr 23
Master Technology Transfer, Manufacturing and Clinical Supply Services Agreement for Bcma Car-t Product
8:30am
CORRESP
0fbwz1qou hzho5e6
11 Oct 22
Correspondence with SEC
12:00am
UPLOAD
7bsu3tqg
6 Oct 22
Letter from SEC
12:00am
CORRESP
cm4j y1j8cqhfva
30 Sep 22
Correspondence with SEC
12:00am
UPLOAD
gr6zt
2 Sep 22
Letter from SEC
12:00am
6-K
EX-1.1
818a5eh
27 Jul 22
Announces Pricing of Public Offering
4:35pm
424B5
v10gm 5lnamo8
27 Jul 22
Prospectus supplement for primary offering
4:32pm
424B5
1h4x582ve63tj73js2zu
25 Jul 22
Prospectus supplement for primary offering
4:29pm
6-K
EX-99.3
u7em7be
25 Jul 22
Legend Biotech Corporation Announces Proposed Public Offering
4:07pm
6-K
txiqsqz6ejbqszrd0g
13 Apr 22
Legend Biotech Corporation Form 6-K
5:30pm
6-K
EX-1.1
dsplv
17 Dec 21
Announces Pricing of Public Offering
4:19pm